Caspase-dependent and -independent death pathways in cancer therapy
- 1 February 2000
- journal article
- review article
- Published by Springer Nature in Apoptosis
- Vol. 5 (1) , 17-20
Abstract
The majority of current anticancer therapies induce tumor cell death through the induction of apoptosis. Alterations in the apoptotic pathways may determine tumor resistance to these therapies....Keywords
This publication has 34 references indexed in Scilit:
- Granzyme A Loading Induces Rapid Cytolysis and a Novel Form of DNA Damage Independently of Caspase ActivationImmunity, 1999
- Adenovirus-mediated expression of Fas ligand induces apoptosis of human prostate cancer cellsCell Death & Differentiation, 1999
- The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosisCell Death & Differentiation, 1998
- Interferon-α enhances CD95L-induced apoptosis of human malignant glioma cellsJournal of Neuroimmunology, 1998
- CD95 ligand-induced apoptosis of human medulloblastoma cellsCancer Letters, 1998
- Chemosensitivity of solid tumor cellsin vitro is related to activation of the CD95 systemInternational Journal of Cancer, 1998
- Resistance to apoptosis correlates with a highly proliferative phenotype and loss of Fas and CPP32 (caspase-3) expression in human leukemia cellsInternational Journal of Cancer, 1998
- Deficient activation of the CD95 (APO-1/Fas) system in drug-resistant cellsLeukemia, 1997
- The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell deathOncogene, 1997
- Target Cell Lysis by CTL Granule Exocytosis Is Independent of ICE/Ced-3 Family ProteasesImmunity, 1997